Rheumatoid Arthritis (RA) Stem Cells and Knee Pain

Rheumatoid arthritis (RA) is a chronic, inflammatory autoimmune disease that primarily affects the joints. The most common symptom of RA is joint pain, which can range from mild to severe. RA can also cause inflammation in other tissues throughout the body, including the skin, eyes, and lungs. RA is a progressive disease, meaning it typically gets worse over time. If left untreated, RA can lead to joint damage and disability. There is no cure for RA, but there are treatments that can help to control the disease and reduce symptoms. One promising new treatment for RA is the use of mesenchymal stem cells (MSCs). MSCs are a type of stem cell that can differentiate into various cell types, including cartilage-forming cells. This makes them a potential treatment for RA, as they could potentially help to repair damaged cartilage and reduce inflammation. A number of studies have been conducted to assess the safety and efficacy of MSCs in the treatment of RA. Overall, the results of these studies are encouraging, with most patients reporting reduced joint pain and inflammation after treatment with MSCs. There are still some limitations to this treatment, however, and further research is needed to confirm its efficacy.

 "Stem Cell Therapy: A Rheumatoid Arthritis Treatment Breakthrough ...." 5 Sep. 2022, https://www.dvcstem.com/post/rheumatoid-arthritis. Accessed 24 Oct. 2022.

 "Stem cell therapy for rheumatoid arthritis: What to know." 27 Jun. 2019, https://www.medicalnewstoday.com/articles/325583. Accessed 24 Oct. 2022.

 "Mesenchymal Stem Cell-Based Therapy for Rheumatoid Arthritis." 27 Oct. 2021, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584240/. Accessed 24 Oct. 2022.

The information below is the recommended stem cell therapy protocol for this condition 

Route of AdministrationDoseTime (Days)Total Cells
IV50,000,0003150,000,000
Myers cocktail/NAD50,000,0001N/A
Intra-articular50,000,000150,000,000
Total200,000,000